The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31 | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31	Frontotemporal Lobar Degeneration, Neurologic Manifestations, Nutritional and Metabolic Diseases, Ocular Motility Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, cranial nerve neuropathy, dementia, eye disorder, frontotemporal dementia, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, ophthalmoplegia, palsy, proteostasis deficiencies, psychiatric disorder, tauopathy	Enrolling by invitation	Phase 2	2026-08-12		NCT07264283

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Adam Boxer	3
Alzheimer's Clinical Trials Consortium	10
Alzheimer's Therapeutic Research Institute	12
Massachusetts General Hospital	758
National Institute on Aging (NIA)	571
PharmatrophiX Inc.	1
University of California, San Diego	337
University of Southern California	216

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of California, San Francisco (UCSF), Memory and Aging Center	San Francisco	United States	3